Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B GOTTLIEB

Showing results (381-390 of 523) with videos related to

Pageof 53
Sort By:
Pediatric Dermatology|September 30, 2005
Low systemic absorption and good tolerability of pimecrolimus, administered as 1% cream (Elidel) in infants with atopic dermatitis--a multicenter, 3-week, open-label studyDoris Staab, David Pariser, Alice B Gottlieb, et al.
The Journal of Clinical and Aesthetic Dermatology|October 24, 2024
Diagnostic Delay of Psoriatic Arthritis of More Than Six Months Contributes to Poor Patient-Reported Outcome Measures in Depression, Social Ability, and Disease Impact: A Cross-sectional StudyMelissa P Zundell, Lourdes Perez-Chada, Neel Tapryal, et al.
Lancet (London, England)|June 18, 2013
Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trialIain B McInnes, Arthur Kavanaugh, Alice B Gottlieb, et al.
Dermatology (Basel, Switzerland)|January 29, 2020
Examination of Treatment Satisfaction Instruments in Psoriasis: 2017 Results from the Psoriasis Working Group of the International Dermatology Outcome Measures (IDEOM)Heather Kornmehl, Kristina Callis Duffin, Nicole Salame, et al.
Dermatology and Therapy|December 11, 2025
Bimekizumab Efficacy and Safety in Patients with Psoriatic Arthritis with Substantial Skin and Nail Psoriasis to 1 YearDiamant Thaçi, Akihiko Asahina, Wolf-Henning Boehncke, et al.
The Journal of Rheumatology|February 1, 2025
Effect of Bimekizumab on Patient-Reported Outcomes and Work Productivity in Patients With Psoriatic Arthritis: 1-Year Results From 2 Phase III StudiesDafna D Gladman, Philip J Mease, Laure Gossec, et al.
Plastic and Reconstructive Surgery|February 8, 2006
Effect of the Veterans Affairs Medical System on plastic surgery residency trainingAdam G Ravin, Neil B Gottlieb, Howard T Wang, et al.
Journal of the American Academy of Dermatology|July 16, 2005
Tacrolimus ointment is safe and effective in the treatment of atopic dermatitis: results in 8000 patientsJohn Y M Koo, Alan B Fleischer, William Abramovits, et al.
Dermatology and Therapy|November 22, 2024
Bimekizumab Efficacy in High-Impact Areas: Pooled 2-Year Analysis in Scalp, Nail, and Palmoplantar Psoriasis from Phase 3/3b Randomized Controlled TrialsJoseph F Merola, Alice B Gottlieb, Andreas Pinter, et al.
Journal of the American Academy of Dermatology|September 27, 2000
Anti-CD4 monoclonal antibody treatment of moderate to severe psoriasis vulgaris: results of a pilot, multicenter, multiple-dose, placebo-controlled studyA B Gottlieb, M Lebwohl, S Shirin, et al.
Pageof 53

Showing results (381-390 of 523) with videos related to

Sort By:
Pageof 53
Pediatric Dermatology|September 30, 2005
Low systemic absorption and good tolerability of pimecrolimus, administered as 1% cream (Elidel) in infants with atopic dermatitis--a multicenter, 3-week, open-label studyDoris Staab, David Pariser, Alice B Gottlieb, et al.
The Journal of Clinical and Aesthetic Dermatology|October 24, 2024
Diagnostic Delay of Psoriatic Arthritis of More Than Six Months Contributes to Poor Patient-Reported Outcome Measures in Depression, Social Ability, and Disease Impact: A Cross-sectional StudyMelissa P Zundell, Lourdes Perez-Chada, Neel Tapryal, et al.
Lancet (London, England)|June 18, 2013
Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trialIain B McInnes, Arthur Kavanaugh, Alice B Gottlieb, et al.
Dermatology (Basel, Switzerland)|January 29, 2020
Examination of Treatment Satisfaction Instruments in Psoriasis: 2017 Results from the Psoriasis Working Group of the International Dermatology Outcome Measures (IDEOM)Heather Kornmehl, Kristina Callis Duffin, Nicole Salame, et al.
Dermatology and Therapy|December 11, 2025
Bimekizumab Efficacy and Safety in Patients with Psoriatic Arthritis with Substantial Skin and Nail Psoriasis to 1 YearDiamant Thaçi, Akihiko Asahina, Wolf-Henning Boehncke, et al.
The Journal of Rheumatology|February 1, 2025
Effect of Bimekizumab on Patient-Reported Outcomes and Work Productivity in Patients With Psoriatic Arthritis: 1-Year Results From 2 Phase III StudiesDafna D Gladman, Philip J Mease, Laure Gossec, et al.
Plastic and Reconstructive Surgery|February 8, 2006
Effect of the Veterans Affairs Medical System on plastic surgery residency trainingAdam G Ravin, Neil B Gottlieb, Howard T Wang, et al.
Journal of the American Academy of Dermatology|July 16, 2005
Tacrolimus ointment is safe and effective in the treatment of atopic dermatitis: results in 8000 patientsJohn Y M Koo, Alan B Fleischer, William Abramovits, et al.
Dermatology and Therapy|November 22, 2024
Bimekizumab Efficacy in High-Impact Areas: Pooled 2-Year Analysis in Scalp, Nail, and Palmoplantar Psoriasis from Phase 3/3b Randomized Controlled TrialsJoseph F Merola, Alice B Gottlieb, Andreas Pinter, et al.
Journal of the American Academy of Dermatology|September 27, 2000
Anti-CD4 monoclonal antibody treatment of moderate to severe psoriasis vulgaris: results of a pilot, multicenter, multiple-dose, placebo-controlled studyA B Gottlieb, M Lebwohl, S Shirin, et al.
Pageof 53